Retrospective Study as First-Line Chemotherapy Combined Anti-VEGF Antibody with Fluoropyrimidine for Frail Patients with Unresectable or Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 1421-9867|87|1|59-64

ISSN： 0012-2823

Source： Digestion, Vol.87, Iss.1, 2013-01, pp. : 59-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping

By  

Medical Principles and Practice, Vol. 23, Iss. 5, 2014-03 ,pp. : 478-481

Karger

Access to resources Recommend Favorite

Anti‐epidermal or anti‐vascular endothelial growth factor as first‐line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients

By  

Journal Of Cachexia Sarcopenia And Muscle, Vol. 6, Iss. 3, 2015-09 ,pp. : 231-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma

By Yamagishi Yoshiyuki   Higuchi Hajime   Izumiya Motoko   Sakai Gen   Iizuka Hideko   Nakamura Shoko   Adachi Masayuki   Hozawa Sigenari   Takaishi Hiromasa   Hibi Toshifumi  

Journal of Gastroenterology, Vol. 45, Iss. 11, 2010-11 ,pp. : 1146-1154

Springer Publishing Company

Access to resources Recommend Favorite

Predictive Value of Optimal Morphologic Response to First-Line Chemotherapy in Patients with Colorectal Liver Metastases

By  

Digestion, Vol. 89, Iss. 1, 2014-01 ,pp. : 43-48

Karger

Access to resources Recommend Favorite

Advances in Chemotherapy against Advanced or Metastatic Colorectal Cancer

By  

Digestion, Vol. 77, Iss. 1, 2008-01 ,pp. : 13-22

Karger

Access to resources Recommend Favorite